Clinical Study

A Phase III Trial Of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus S

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Specialties:
  • Type of Study: Drug

This study will compare radiation therapy given with a higher daily dose over 3 weeks with a boost given each day compared with standard radiation followed by a boost given on separate days which extends over 6 weeks. Patients will get either a standard daily dose of radiation therapy to the whole b

Criteria:

Eligible Patients Must Have Breast Cancer That Was Removed By Lumpectomy

Keywords:

Breast, Breast Cancer, Early Stage, Rtog 1005

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.